Table 2.

Drugs predicted to influence largest number of immune subset changes.

Drug	Subset changes	Status	Drug class
Irinotecan	60	Approved	Topoisomerase inhibitor
Puromycin	58	Experimental	Aminonucleoside antibiotic
Deptropine	55	Approved	Anti-histamine
Tyrphostin AG-825	54	Experimental	Tyrosine kinase inhibitor
0175029-0000	54	Experimental	Unknown
Daunorubicin	54	Approved	Anthracycline
Medrysone	53	Approved	Corticosteroid
Bepridil	52	Approved	Calcium channel blocker
Etacrynic acid	52	Approved	Loop diuretic
Alsterpaullone	52	Experimental	Cyclin-dependent kinase inhibitor
Primaquine	51	Approved	Aminoquinoline
Procaine	50	Approved	Local anesthetic
Gliclazide	50	Approved	Anti-diabetic
Cinchonine	50	Experimental	Alkaloid
Piperidolate	50	Approved	Anti-cholinergic